Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-012926
Filing Date
2019-05-09
Accepted
2019-05-09 18:51:14
Documents
1
Period of Report
2019-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4025
  Complete submission text file 0000899243-19-012926.txt   5420
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SOLID BIOSCIENCES, LLC 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address
Sullivan Lynne Marie (Reporting) CIK: 0001727640 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38359 | Film No.: 19812292